Nanjing Medlander (China) Performance
| 688273 Stock | 25.66 0.54 2.15% |
On a scale of 0 to 100, Nanjing Medlander holds a performance score of 9. The company secures a Beta (Market Risk) of -0.21, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Nanjing Medlander are expected to decrease at a much lower rate. During the bear market, Nanjing Medlander is likely to outperform the market. Please check Nanjing Medlander's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Nanjing Medlander's current price movements will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nanjing Medlander Medical are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nanjing Medlander sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0398 | Payout Ratio 0.5845 | Forward Dividend Rate 1 | Ex Dividend Date 2024-10-08 |
1 | Weak Statutory Earnings May Not Tell The Whole Story For Nanjing Medlander Medical TechnologyLtd - Simply Wall St | 11/08/2024 |
| Begin Period Cash Flow | 1.2 B |
Nanjing |
Nanjing Medlander Relative Risk vs. Return Landscape
If you would invest 2,085 in Nanjing Medlander Medical on September 1, 2024 and sell it today you would earn a total of 481.00 from holding Nanjing Medlander Medical or generate 23.07% return on investment over 90 days. Nanjing Medlander Medical is generating 0.4138% of daily returns and assumes 3.5554% volatility on return distribution over the 90 days horizon. Simply put, 31% of stocks are less volatile than Nanjing, and 92% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Nanjing Medlander Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nanjing Medlander's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nanjing Medlander Medical, and traders can use it to determine the average amount a Nanjing Medlander's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1164
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688273 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.56 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.41 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Nanjing Medlander is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nanjing Medlander by adding it to a well-diversified portfolio.
Nanjing Medlander Fundamentals Growth
Nanjing Stock prices reflect investors' perceptions of the future prospects and financial health of Nanjing Medlander, and Nanjing Medlander fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nanjing Stock performance.
| Return On Equity | 0.0776 | ||||
| Return On Asset | 0.0386 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.31 % | ||||
| Current Valuation | 1.61 B | ||||
| Shares Outstanding | 100 M | ||||
| Price To Book | 1.92 X | ||||
| Price To Sales | 6.74 X | ||||
| Revenue | 340.82 M | ||||
| Gross Profit | 376.75 M | ||||
| EBITDA | 105.63 M | ||||
| Net Income | 89.82 M | ||||
| Total Debt | 6.13 M | ||||
| Book Value Per Share | 13.38 X | ||||
| Cash Flow From Operations | 136.91 M | ||||
| Earnings Per Share | 1.03 X | ||||
| Total Asset | 1.53 B | ||||
| Retained Earnings | 244.7 M | ||||
About Nanjing Medlander Performance
By analyzing Nanjing Medlander's fundamental ratios, stakeholders can gain valuable insights into Nanjing Medlander's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nanjing Medlander has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nanjing Medlander has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nanjing Medlander is entity of China. It is traded as Stock on SHG exchange.Things to note about Nanjing Medlander Medical performance evaluation
Checking the ongoing alerts about Nanjing Medlander for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nanjing Medlander Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nanjing Medlander had very high historical volatility over the last 90 days | |
| Nanjing Medlander is unlikely to experience financial distress in the next 2 years | |
| About 69.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Weak Statutory Earnings May Not Tell The Whole Story For Nanjing Medlander Medical TechnologyLtd - Simply Wall St |
- Analyzing Nanjing Medlander's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nanjing Medlander's stock is overvalued or undervalued compared to its peers.
- Examining Nanjing Medlander's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nanjing Medlander's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nanjing Medlander's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nanjing Medlander's stock. These opinions can provide insight into Nanjing Medlander's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nanjing Stock analysis
When running Nanjing Medlander's price analysis, check to measure Nanjing Medlander's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanjing Medlander is operating at the current time. Most of Nanjing Medlander's value examination focuses on studying past and present price action to predict the probability of Nanjing Medlander's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanjing Medlander's price. Additionally, you may evaluate how the addition of Nanjing Medlander to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |